Structural Formula (9ca46d47 3a27 47d8 B2ca A2f5719a8042 01)
Hydroxyzine Hydrochloride Tablet, Film Coated
Product Images NDC 16571-113
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Hydrochloride (NDC 16571-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (9ca46d47 3a27 47d8 B2ca A2f5719a8042 02)
This text appears to be a description of a medication. The medication is identified as "P=Rising NDC16571-113-01" and each tablet contains 10 mg of hydroxyzine hydrochloride. It is manufactured by Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India. The recommended dosage information and full prescribing information can be found in the package insert. The medication is distributed by Hydrochloride Store and must be stored at a temperature of 20°-25°C (68°-77°F). It is dispensed in a tight container as defined in the USP, with a child-resistant closure. The text also emphasizes the importance of keeping the medication out of reach of children. The pack contains 100 tablets and has a size of approximately 15 mm.*
Image (9ca46d47 3a27 47d8 B2ca A2f5719a8042 03)
This is a description of a medication called hydroxyzine hydrochloride, which comes in tablet form. Each tablet contains 25 mg of the active ingredient. The usual dosage and other important information can be found in the package insert. The medication should be stored at a temperature of 20°-25°C (68°-77°F). It should be kept in a tight container with a child-resistant closure. It is important to keep this medication out of reach of children. The package contains 100 tablets and was issued in July 2023. The medication is manufactured by Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India, and distributed by Rising Pharma Holdings, Inc. The provided manufacturing license number is 12/SRD/TS/2017/F/G 03011000439.*
Image (9ca46d47 3a27 47d8 B2ca A2f5719a8042 04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
